Headlines on the fledgling marijuana industry.
Ticker | Name | Last | Chg | Chg % | |
---|---|---|---|---|---|
ACB | Aurora Cannabis Inc. |
|
|
|
|
CRON | Cronos Group Inc. |
|
|
|
|
WEED | Canopy Growth Corp. |
|
|
|
|
GWPH | GW Pharmaceuticals PLC ADR |
|
|
|
|
TLRY | Tilray Inc. Cl 2 |
|
|
|
Cannabis Watch: Canopy revenue grows, but Tilray’s sales are stagnant and Aurora sales decline while a prominent partnership costs $40 million to end
‘While Tuesday night’s election did not clearly show who America thinks should lead the nation, it did make clear that we are united on replacing our country’s archaic cannabis laws,’ says CCPC
‘I would say this was one of the best case scenarios for cannabis investors,’ says Korey Bauer, portfolio manager of the Cannabis Growth Fund
Aurora names CCO Miguel Martin as new CEO
FDA outlines road to approval involves clinical trials
‘While these were nominally antitrust investigations, and used antitrust investigative ities, they were not bona fide antitrust investigations,’ says John Elias
Canopy’s huge loss resulted from shuttered facilities and obsolete packaging, marijuana
Reliva had been trying to raise venture-capital money at a $40 million valuation before taking that amount in Aurora stock for acquisition
Aurora shares surge nearly 30% in the extended session
Interim chief executive Michael Singer says Aurora is using video meetings and drone tours of facilities, and is willing to hire a new leader without an in-person meeting
‘We think ACB can become a solid cash-flow generator simply from the Canadian operations,’ Ladenburg Thalmann analyst says
Shares rise nearly 70% on volume more than 30 times greater than average after pot company reports stronger-than-expected revenue growth
Having access to the CARE Act’s Paycheck Protection Program would have been a lifeline for these companies, owners say
International medical cannabis sales exceed those in Canada, CEO says cannabis revenue has picked up amid global pandemic
Canadian pot company was facing delisting by New York Stock Exchange as shares traded for less than $1
Data suggests that consumers stocked up on pot at end of March, but the surge likely didn’t continue into April
‘This is the first time I’ve seen the federal trade associations for cannabis rolling in the same direction,’ insider says of lobbying efforts
The sector was already shaky before COVID-19, but companies must now have the right mix of cash, pot and sales channels to make it to the other side